SATO VICKI L — SEC Form 4 filings
SEC reporting owner CIK 1197020. 30 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2024-01-18 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 24 filings — 318,035 shares, $2,710,264 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 42,177 shares @ $9.75 ($411,314) in Vir Biotechnology, Inc., filed 2026-02-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | Director | 15 | — | 15 legs · 295,337 sh · $2,196,692 | 6 |
| Denali Therapeutics Inc. (DNLI) | Director | 12 | — | 13 legs · 22,698 sh · $513,572 | 2 |
| Allogene Therapeutics, Inc. (ALLO) | Director | 3 | — | — | 4 |
Form 4 filings — SATO VICKI L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 95,400 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $10.05 | EDGAR |
| 2026-04-02 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $9.07 | EDGAR |
| 2026-03-03 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 21,800 @ $9.50 · Sale (S): 200 @ $9.98 | EDGAR |
| 2026-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Option exercise (M): 42,377 @ $1.49 · Sale (S): 42,177 @ $9.75 · Sale (S): 200 @ $10.26 · Option exercise (M): 42,377 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $7.71 | EDGAR |
| 2026-01-05 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $5.93 | EDGAR |
| 2025-12-02 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $6.00 | EDGAR |
| 2025-11-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $5.64 | EDGAR |
| 2025-10-02 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $5.84 | EDGAR |
| 2025-09-03 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $4.99 | EDGAR |
| 2025-08-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $4.99 | EDGAR |
| 2025-07-02 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 22,000 @ $5.10 | EDGAR |
| 2025-06-23 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 144,400 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 10,960 @ $12.52 | EDGAR |
| 2025-01-03 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 3,080 @ $20.91 | EDGAR |
| 2024-11-12 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,020 @ $30 | EDGAR |
| 2024-11-05 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 3,080 @ $27.07 | EDGAR |
| 2024-09-16 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,020 @ $30 | EDGAR |
| 2024-09-04 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,980 @ $24.99 · Sale (S): 100 @ $25.37 | EDGAR |
| 2024-07-03 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,980 @ $22.12 · Sale (S): 100 @ $22.86 | EDGAR |
| 2024-06-07 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 61,475 @ $0 · Grant/award (A): 95,541 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 5,967 @ $0 · Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,674 @ $20.39 | EDGAR |
| 2024-04-17 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,666 @ $18.29 | EDGAR |
| 2024-03-19 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,666 @ $20.10 | EDGAR |
| 2024-02-20 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,666 @ $18.37 | EDGAR |
| 2024-01-18 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 1,666 @ $18.42 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197020 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →